Literature DB >> 12535520

Structural determinants of integrin recognition by talin.

Begoña García-Alvarez1, José M de Pereda, David A Calderwood, Tobias S Ulmer, David Critchley, Iain D Campbell, Mark H Ginsberg, Robert C Liddington.   

Abstract

The binding of cytoplasmic proteins, such as talin, to the cytoplasmic domains of integrin adhesion receptors mediates bidirectional signal transduction. Here we report the crystal structure of the principal integrin binding and activating fragment of talin, alone and in complex with fragments of the beta 3 integrin tail. The FERM (four point one, ezrin, radixin, and moesin) domain of talin engages integrins via a novel variant of the canonical phosphotyrosine binding (PTB) domain-NPxY ligand interaction that may be a prototype for FERM domain recognition of transmembrane receptors. In combination with NMR and mutational analysis, our studies reveal the critical interacting elements of both talin and the integrin beta 3 tail, providing structural paradigms for integrin linkage to the cell interior.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12535520     DOI: 10.1016/s1097-2765(02)00823-7

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  205 in total

1.  Engineered allosteric mutants of the integrin alphaMbeta2 I domain: structural and functional studies.

Authors:  Clare J McCleverty; Robert C Liddington
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

2.  Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling.

Authors:  David A Calderwood; Yosuke Fujioka; Jose M de Pereda; Begoña García-Alvarez; Tetsuya Nakamoto; Ben Margolis; C Jane McGlade; Robert C Liddington; Mark H Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

3.  Phox homology band 4.1/ezrin/radixin/moesin-like proteins function as molecular scaffolds that interact with cargo receptors and Ras GTPases.

Authors:  Rajesh Ghai; Mehdi Mobli; Suzanne J Norwood; Andrea Bugarcic; Rohan D Teasdale; Glenn F King; Brett M Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-21       Impact factor: 11.205

Review 4.  The integrin-actin connection, an eternal love affair.

Authors:  Cord Brakebusch; Reinhard Fässler
Journal:  EMBO J       Date:  2003-05-15       Impact factor: 11.598

5.  Suppression of integrin activation by the membrane-distal sequence of the integrin alphaIIb cytoplasmic tail.

Authors:  Jun Yamanouchi; Takaaki Hato; Tatsushiro Tamura; Shigeru Fujita
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

6.  A membrane proximal region of the integrin alpha5 subunit is important for its interaction with nischarin.

Authors:  Suresh K Alahari; Hani Nasrallah
Journal:  Biochem J       Date:  2004-01-15       Impact factor: 3.857

7.  FERM domain interaction promotes FAK signaling.

Authors:  Jill M Dunty; Veronica Gabarra-Niecko; Michelle L King; Derek F J Ceccarelli; Michael J Eck; Michael D Schaller
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

8.  Talin Plays a Critical Role in the Maintenance of the Regulatory T Cell Pool.

Authors:  Jane E Klann; Kelly A Remedios; Stephanie H Kim; Patrick J Metz; Justine Lopez; Lauren A Mack; Ye Zheng; Mark H Ginsberg; Brian G Petrich; John T Chang
Journal:  J Immunol       Date:  2017-05-17       Impact factor: 5.422

9.  A talin mutant that impairs talin-integrin binding in platelets decelerates αIIbβ3 activation without pathological bleeding.

Authors:  Lucia Stefanini; Feng Ye; Adam K Snider; Kasra Sarabakhsh; Raymond Piatt; David S Paul; Wolfgang Bergmeier; Brian G Petrich
Journal:  Blood       Date:  2014-02-28       Impact factor: 22.113

10.  Leukocyte adhesion deficiency-III is caused by mutations in KINDLIN3 affecting integrin activation.

Authors:  Lena Svensson; Kimberley Howarth; Alison McDowall; Irene Patzak; Rachel Evans; Siegfried Ussar; Markus Moser; Ayse Metin; Mike Fried; Ian Tomlinson; Nancy Hogg
Journal:  Nat Med       Date:  2009-02-22       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.